J. Hiserodt

发表

Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat.

P. Disaia, T. Hamilton, G. Granger, 1996, American journal of obstetrics and gynecology.

In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells.

A. Maghazachi, R. Herberman, J. Hiserodt, 1988, Cellular immunology.

Generation and characterization of purified adherent lymphokine-activated killer cells in mice.

R. Herberman, J. Hiserodt, N. Vujanović, 1989, Journal of immunology.

CD8+ T-cells are Required for Adoptive Transfer of the BB Rat Diabetic Syndrome

P. Edouard, P. Poussier, J. Hiserodt, 1993, Diabetes.

In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats

M. V. D. van den Brink, J. Hiserodt, L. E. Hunt, 1990, The Journal of experimental medicine.

The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures

M. V. D. van den Brink, S. Boggs, J. Hiserodt, 1990, The Journal of experimental medicine.

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells

A. Deleo, W. Chambers, R. Herberman, 1989, The Journal of experimental medicine.

NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.

W. Seaman, J. Ryan, J. Hiserodt, 1991, Journal of immunology.

Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro.

G. Parham, P. Hermonat, A. Santin, 1999, Immunobiology.

Laminin receptor expression on murine tumor cells: Correlation with sensitivity to natural cell‐mediated cytotoxicity

J. Varani, J. Hiserodt, K. A. Laybourn, 1989, International journal of cancer.

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

A. Maghazachi, R. Herberman, J. Hiserodt, 1988, The Journal of experimental medicine.

Role of Soluble Cytotoxic Factors in Lymphokine‐Activated Killer Cell (LAK)‐Mediated Cytotoxicity

W. Chambers, J. Hiserodt, 1988, Annals of the New York Academy of Sciences.

Chapter 9 Monoclonal antibodies directed against small cell carcinomas define by flow cytometry phenotypic differences among small cell and non-small cell carcinomas, neuroblastomas, and lymphoblastoid cell line

M. Wagner, E. Klein, J. Lange, 1988 .

Development and in vitro characterization of a GM-CSF secreting human ovarian carcinoma tumor vaccine

P. Disaia, G. Granger, M. Graf, 1995, International Journal of Gynecologic Cancer.

A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.

T. Whiteside, R. Melder, R. Herberman, 1988, Cancer research.

Lymphokine-activated killer cells: biology and relevance to disease.

J. Hiserodt, 1993, Cancer investigation.

Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.

M. V. D. van den Brink, R. Herberman, J. Hiserodt, 1989, Cellular immunology.

Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.

W. Chambers, R. Herberman, J. Hiserodt, 1988, Annales de l'Institut Pasteur. Immunology.

Effects of cytokines combined with high‐dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule‐1 in human ovarian cancers

P. Disaia, G. Granger, A. Santin, 1996, International journal of cancer.

NKR-P1+ cells in the rat uterus: granulated metrial gland cells are of the natural killer cell lineage.

J. D. Young, J. Hiserodt, C. Kresge, 1994, Biology of reproduction.

Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic.

R. Schwarz, R. Schwarz, J. Hiserodt, 1989, Cancer research.

Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.

R. Herberman, J. Hiserodt, N. Vujanović, 1988, Cancer research.

Lymphokine-activated Killer Cells in Rats : Analysis of Progenitor and Effector Cell Phenotype and Relationship to Natural Killer Cells 1

Craig W. Reynolds, R. Herberman, M. W. Olszowy, 2006 .

In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats.

J. Hiserodt, R. Felgar, 1990, Cellular immunology.

Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.

Craig W. Reynolds, R. Herberman, M. W. Olszowy, 1988, Cancer research.

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

J. Ritz, L. Lanier, J. Phillips, 1987, Immunology today.

Effects of splenectomy on the development of tumor-specific immunity.

R. E. Schwarz, R. Schwarz, J. Hiserodt, 1990, The Journal of surgical research.

Development and characterization of an IL-4-secreting human ovarian carcinoma cell line.

R. Burger, P. Disaia, M. Graf, 1995, Gynecologic oncology.

Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation.

D. Cramer, J. Harnaha, J. Hiserodt, 1988, Transplantation.

The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer.

R. Batchu, G. Parham, P. Hermonat, 1998, International journal of radiation biology.

Expression and cytokine mediated modulation of adhesion/costimulation molecules ICAM‐1(CD54) and LFA‐3(CD58) in human ovarian cancer

G. Parham, P. Hermonat, A. Santin, 1997 .

Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer.

P. Disaia, G. Granger, A. Santin, 1996, Gynecologic oncology.

Effects of irradiation on the expression of surface antigens in human ovarian cancer.

P. Disaia, G. Granger, A. Santin, 1996, Gynecologic oncology.

The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro.

R. Yamamoto, G. Granger, J. Lewis, 1978, Cellular immunology.

Distribution of lymphocyte subsets in rat milk from normal and Trichinella spiralis-infected rats.

J. Hiserodt, L. Seelig, H. Na, 1992, Journal of reproductive immunology.

In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats.

M. V. D. van den Brink, M. Palomba, P. Basse, 1991, Cancer research.

The human LT system: VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes☆

G. Granger, S. Ford, J. Hiserodt, 1978 .

Development and characterization of an interleukin-2-transduced human ovarian carcinoma vaccine not expressing major histocompatibility complex molecules tumor

G. Granger, A. Santin, S. Pecorelli, 2004 .

Development and characterization of an interleukin‐2‐transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules

P. Disaia, G. Granger, G. Ioli, 1996, American journal of obstetrics and gynecology.

Cytotoxic and Growth Inhibitory Lymphokines

C. Ware, G. Granger, J. Hiserodt, 1979 .

A Comparison of Blood Lipid and Lipoprotein Values in Young Adults Who Die Suddenly and Unexpectedly from Atherosclerotic Coronary Artery Disease With Other Noncardiac Deaths

T. Orchard, J. Perper, S. Koehler, 1995, The American journal of forensic medicine and pathology.

Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism

R. Schmidt, W. Hickey, J. Hiserodt, 1992, The Journal of experimental medicine.

Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat.

M. V. D. van den Brink, R. Herberman, J. Hiserodt, 1991, Blood.

Effects of in vivo treatment with FK506 on natural killer cells in rats.

T. Starzl, M. V. D. van den Brink, J. Fung, 1991, Transplantation.

Mechanisms of target cell killing by natural killer cells.

J. Ortaldo, J. Hiserodt, 1989, Current opinion in immunology.

Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells.

J. Varani, J. Hiserodt, K. A. Laybourn, 1985, Journal of immunology.

Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis.

S. Targan, J. Hiserodt, L. Britvan, 1983, Journal of immunology.

Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.

S. Targan, J. Hiserodt, L. Britvan, 1983, Journal of immunology.

Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages.

S. Targan, J. Hiserodt, L. Britvan, 1982, Journal of immunology.

Inhibition of human natural killing by heterologous and monoclonal antibodies.

S. Targan, J. Hiserodt, L. Britvan, 1982, Journal of immunology.

Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps.

S. Targan, J. Hiserodt, L. Britvan, 1982, Journal of immunology.

Lymphokine-activated Killer Cells in Rats : Analysis of Tissue and Strain Distribution , Ontogeny , and Target Specificity 1

R. Herberman, J. Hiserodt, N. Vujanović, 2006 .

The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease

S. Targan, R. Stevens, B. Korelitz, 1985, Journal of Clinical Immunology.

Inhibition of neutrophil and natural killer cell function by human seminal fluid acid phosphatase.

J. Dowling, A. Saha, R. Glew, 1989, Clinica chimica acta; international journal of clinical chemistry.

The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cells from several animal species.

G. Granger, P. Horn, J. Hiserodt, 1979, Journal of immunology.

The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated on lectin-coated allogeneic monolayers in vitro.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

Macrophage Colony-Stimulating Factor Membrane-Associated Isoform of Genetically Engineered to Express the Glioblastoma Multiforme Using Tumor Cells Development of Systemic Immunity to Wepsic and

G. Granger, M. Graf, M. Jadus, 1999 .

Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas.

D. Remick, S. Kunkel, S. Chensue, 1988, The American journal of pathology.

The importance of splenectomy for the adoptive immunotherapy of cancer.

R. Schwarz, J. Hiserodt, 1989, Medical hypotheses.

Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type.

T. Medsger, V. Steen, J. Hiserodt, 1988, Arthritis and rheumatism.

A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicity.

J. Hiserodt, 1985, Advances in experimental medicine and biology.

NKR-P1, a signal transduction molecule on natural killer cells.

W. Chambers, R. Giorda, M. Trucco, 1990, Science.

In Vitro and in Vivo Interaction between Murine Fibrosarcoma Cells and Natural Killer Cells 1

L. Abruzzo, J. Varani, J. Hiserodt, 2006 .

In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.

L. Abruzzo, J. Varani, J. Hiserodt, 1986, Cancer research.

Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes.

J. Varani, J. Hiserodt, K. A. Laybourn, 1985, The American journal of pathology.

Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: evidence for blocking of both recognition and lethal hit stages of cytolysis.

B. Bonavida, J. Hiserodt, R. Kahle, 1983, Cellular immunology.

Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.

J. Hiserodt, M. Neville, 1982, Journal of immunology.

Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes.

B. Bonavida, J. Hiserodt, 1979, Journal of immunology.

The LT system in experimental animals. I. Rapid release of high levels of lymphotoxin (LT) activity from murine lymphocytes during the interaction with lectin-treated allogeneic or xenogeneic target cells in vitro.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

Laminin production by murine melanoma cells: possible involvement in cell motility

R. Ruddon, J. Varani, S. Fligiel, 1986, Clinical & Experimental Metastasis.

The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat.

O. Blair, J. Bellanti, D. Sobel, 1995, Journal of autoimmunity.

Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.

A. Maghazachi, R. Herberman, J. Hiserodt, 1988, Journal of immunology.

Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.

G. Granger, M. Graf, M. Jadus, 1997, Journal of immunology.

The LT system in experimental animals. IV. Rapid specific lysis of 51CR-labeled allogeneic target cells by highly unstable high m.w. lymphotoxin-receptor complex(es) released in vitro by activated alloimmune murine T lymphocytes.

G. Granger, J. Hiserodt, G. J. Tiangco, 1979, Journal of immunology.

Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix.

G. Parham, P. Hermonat, A. Santin, 1997, Gynecologic oncology.

The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s).

R. Yamamoto, G. Granger, J. Hiserodt, 1979, Cellular immunology.

Molecular Interactions in T‐Cell‐Mediated Cytotoxicity

R. Effros, B. Bonavida, H. Wexler, 1983, Immunological reviews.

Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer.

G. Parham, J. Woodliff, P. Hermonat, 1997, International journal of radiation oncology, biology, physics.

THE LT SYSTEM IN EXPERIMENT AL ANIMALS IV. Rapid Specific Lysis of 51 CR-Labeled Allogeneic Target Cells by Highly Unstable High M.W. Lymphotoxin-Receptor Complex(es) Released in Vitro by Activated Alloimmune Murine T Lymphocytes 1

G. Granger, J. Hiserodt, G. J. Tiangco, 2006 .

RAPID SPECIFIC LYSIS OF CR-51-LABELED ALLOGENEIC TARGET-CELLS BY HIGHLY UNSTABLE HIGH MW LYMPHOTOXIN-RECEPTOR COMPLEX ( ES ) RELEASED INVITRO BY ACTIVATED ALLOIMMUNE MURINE LYMPHOCYTES-T Permalink

G. Granger, J. Hiserodt, G. J. Tiangco, 2006 .

Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer.

G. Parham, P. Hermonat, A. Santin, 1998, Gynecologic oncology.

Surface Structures Involved in Tumor Cell Recognition by Fresh and IL-2-Activated Natural Killer Cells

R. Schwarz, J. Hiserodt, M. Brink, 2018 .

Lak Cells and Autologous Bone Marrow Transplantation: Toward a Cure for Leukemia 1

D. Cramer, J. Hiserodt, M. Brink, 2018 .

Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cells.

J. Hiserodt, R. Felgar, 1992, Cellular immunology.

The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

T-cell membrane antigens associated with cytotoxic function.

J. Fan, B. Bonavida, J. Hiserodt, 1982, Immunology today.

In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA).

B. Tromberg, M. Berns, P. Disaia, 1997, Gynecologic oncology.

The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro.

C. Ware, G. Granger, J. Hiserodt, 1977, Cellular immunology.

Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.

G. Granger, J. Hiserodt, 1977, Journal of immunology.

Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro.

G. Granger, J. Hiserodt, D. Fair, 1976, Journal of immunology.

In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes.

G. Granger, J. Hiserodt, 1976, Cellular immunology.

In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro.

A. Prieur, G. Granger, J. Hiserodt, 1976, Cellular immunology.

Is there evidence for transfer of materials from the killer cell to the target requisite for target cell lysis?

W. Chambers, J. Hiserodt, 1987, Annales de l'Institut Pasteur. Immunology.

ULTRASTRUCTURAL ANALYSIS OF HUMAN NATURAL KILLER CELL - TARGET CELL INTERACTIONS LEADING TO TARGET CELL LYSIS

J. Hiserodt, T. Beals, 1985 .

Studies on the mechanism of the human natural killer cell lethal hit: a new method for rapid physical isolation of lethally hit K562 targets and inhibition of cytolysis by reduced temperature or trypsin.

S. Targan, J. Hiserodt, L. Britvan, 1984, Cellular immunology.

Effect of selective depletion of natural killer cells on allograft rejection.

M. V. D. van den Brink, D. Cramer, J. Harnaha, 1991, Transplantation proceedings.

Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment

M. Altfeld, B. Gazzard, G. Nuovo, 2010, Alimentary pharmacology & therapeutics.

Effects of retinoic acid combined with interferon‐gamma on the expression of major‐histocompatibility‐complex molecules and intercellular adhesion molecule‐1 in human cervical cancer

E. Tian, G. Parham, P. Hermonat, 1998, International journal of cancer.

Lymphocyte and monocyte‐induced motility of MCF‐7 cells by tumor necrosis factor‐α

P. Carpenter, J. Hiserodt, Hoa P. Nguyen, 1997, International journal of cancer.

The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules.

R. Yamamoto, G. Granger, J. Hiserodt, 1978, Cellular immunology.

In vivo induced allo-reactive natural killer cells.

J. Hansson, G. Hedlund, M. Dohlsten, 1992, Journal of immunology.

Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation.

D. Remick, S. Kunkel, J. Hiserodt, 1988, Journal of immunology.

Natural cell-mediated immunity in the rabbit.

S. Sell, D. Strayer, J. Hunt, 1990, Cellular immunology.

Blocking of the induction and expression of immunologically functional T lymphocytes by rat antiactivated T-cell serum.

R. Effros, J. Fan, B. Bonavida, 1982, Cellular immunology.

Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity.

J. Fan, B. Bonavida, J. Hiserodt, 1983, Cellular immunology.

Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.

D. Cramer, J. Harnaha, J. Hiserodt, 1990, Bone marrow transplantation.